Protagonist Therapeutics, Inc. (PTGX)
PTGXProtagonist Therapeutics, Inc.loading…
loading…
QTick signal
+5net
3 bull / 1 bear factors · leaningBull 6 pts·Bear 1 pts30d
loading…
Market context—Sector read · not on fileOKBalance sheet · Safe—PCE inflation days · not on fileRiskFalling knife · 76/100 · was 16 on Sep 21 · as of 2026-09-252/6Bottom watch · 2 of 6 confirmations
Chart pattern
Golden cross
50d above 200d · bullish structure
Volume vs its own 20-session average1.21×
52-week range$62.24 – $160.81
Below high since 2016-11.8% · $160.81 high
Risk / reward0.23 : 1
Plan stop$130.64
Max pain$95.00 options cluster
RSI 1446.0 fires under 35 · fires near $135.48
Forensic flags1 review
Earnings multiple141.4× trailing · forward n.m., a loss is expected
P/E vs its own pastnot on file
Free cash flow yield0.6% · of market value
Last session traded in line with its own normal, price up 3.3%. Over the last 20 sessions, 58% of the volume traded on days the stock closed lower.
Entry strategy · 10 triggers
3 of 6 aligned — closing inRSI 14
●
46.0
fires under 35 · fires near $135.48
vs 50-day
✓
$144.60
below the line
Bollinger
●
$138.90
no lower pierce · fires near $138.14
VWAP 20
✓
$144.22
below the rolling VWAP
Entry level
✓
$141.15
within 1% of model level
Put wall
●
$95.00
2026-10-16 expiry · chain of 2026-09-24
MACD
Context●
-0.62
below zero · rising toward the flip
RVolStatic
1.21×
in line with its own normal
Short int.Static
14.7%
short interest below 20%
ATRStatic
$5.26
14-session average true range
A checklist, not odds on a return: 4 of 6 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
2026-11-05
in 30 sessions
Next dividend
No indicated yield
no forward dividend on file